What is Rubix LS?
Founded in 2016 and based in Lawrence, Massachusetts, Rubix LS is a culturally-centric life science research firm dedicated to building data, products, processes, and programs that comprehensively support the clinical research continuum. A key focus for the company is the inclusion of minority data sets across all phases of the life science development ecosystem. Rubix LS aims to eradicate rare diseases through transformative research and development, coupled with breakthroughs in engineering, positioning itself as a critical player in equitable healthcare innovation.
How much funding has Rubix LS raised?
Rubix LS has raised a total of $1.3M across 1 funding round:
Angel/Seed
$1.3M
Angel/Seed (2021): $1.3M, investors not publicly disclosed
What's next for Rubix LS?
The recent major strategic investment signals a pivotal growth phase for Rubix LS. This capital infusion is expected to accelerate the company's efforts in developing and deploying data-driven solutions for clinical research, with a particular emphasis on addressing underserved populations and rare diseases. Rubix LS is poised to expand its research capabilities, enhance its product offerings, and forge strategic partnerships to further its mission of achieving breakthroughs in life sciences and engineering, ultimately contributing to a more inclusive and effective healthcare landscape.
See full Rubix LS company page
